|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| (Income) loss from discontinued operations | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Noncash revenues, expenses, gains and losses included in income (loss): | |||||
| Net losses on sales of securities available for sale and other assets | |||||
| Net (gain) loss on divestitures and other | |||||
| (Gain) loss on extinguishment of debt | |||||
| Unrealized (gains) losses in earnings - net | |||||
| Change in the fair value of market risk benefits in earnings, net | |||||
| Equity in income from equity method investments, net of dividends or distributions | |||||
| Depreciation and other amortization | |||||
| Impairments of assets | |||||
| Changes in operating assets and liabilities: | |||||
| Insurance reserves | |||||
| Premiums and other receivables and payables - net | |||||
| Reinsurance assets, net | |||||
| Capitalization of deferred policy acquisition costs | |||||
| Current and deferred income taxes - net | |||||
| Other, net | |||||
| Total adjustments | |||||
| Net cash provided by operating activities - continuing operations | |||||
| Net cash used in operating activities - discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from (payments for) | |||||
| Sales or distributions of: | |||||
| Available for sale securities | |||||
| Other securities | |||||
| Other invested assets | |||||
| Divestitures, net | |||||
| Maturities of fixed maturity securities available for sale | |||||
| Principal payments received on and sales of mortgage and other loans receivable | |||||
| Purchases of: | |||||
| Available for sale securities | |||||
| Other securities | |||||
| Other invested assets | |||||
| Mortgage and other loans receivable | |||||
| Net change in short-term investments | |||||
| Other, net | |||||
| Net cash provided by (used in) investing activities - continuing operations | |||||
| Net cash used in investing activities - discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from (payments for) | |||||
| Policyholder contract deposits | |||||
| Policyholder contract withdrawals | |||||
| Issuance of long-term debt | |||||
| Consolidated Entity, Excluding Consolidated VIE | |||||
| Consolidated VIE | |||||
| Total issuance of long-term debt | |||||
| Repayments of debt | |||||
| Consolidated Entity, Excluding Consolidated VIE | |||||
| Consolidated VIE | |||||
| Total repayments of debt | |||||
| Repayments of delayed draw term loan agreement | |||||
| Borrowings under delayed draw term loan agreement | |||||
| Purchase of common stock | |||||
| Redemption of preferred stock | |||||
| Dividends on preferred stock and preferred stock redemption premiums | |||||
| Dividends on common stock | |||||
| Net cash used in financing activities - continuing operations | |||||
| Net cash provided by financing activities - discontinued operations | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and restricted cash | |||||
| Net decrease in cash and restricted cash | |||||
| Cash and restricted cash at beginning of year | |||||
| Cash and restricted cash of held for sale assets | |||||
| Cash and restricted cash at end of year | |||||
| Supplementary Disclosure of Condensed Consolidated Cash Flow Information | |||||
| Cash Equivalents, Restricted Cash and Restricted Cash Equivalents: | |||||
| Cash | |||||
| Consolidated VIE | |||||
| Total cash | |||||
| Restricted cash included in Short-term investments | |||||
| Restricted cash included in Other assets | |||||
| Total cash and restricted cash shown in the Consolidated Statements of Cash Flows | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Taxes | |||||
| Non-cash investing activities: | |||||
| Fixed maturity securities available for sale received in connection with pension risk transfer transactions attributed to discontinued operations | |||||
| Fixed maturity securities and other invested assets received in connection with reinsurance transactions | |||||
| Fixed maturity securities and other invested assets transferred in connection with reinsurance transactions | |||||
| Non-cash consideration received from sale of Validus Re | |||||
| Interest credited to policyholder contract deposits included in financing activities | |||||
| Fee income debited to policyholder contract deposits included in financing activities | |||||
Loading...